Skip to main content
. 2023 Jun 26;18(6):e0287378. doi: 10.1371/journal.pone.0287378

Table 2. Incidence rates per 100,000 and average annual change of IPD among the people 65 years old and older, by vaccine serotypes, in 2010–2019 in Denmark, Finland, Norway and Sweden.

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Average annual change over study period (%) (95% confidence interval) p-value
Denmark
Total 54.0 52.2 50.9 43.3 42.9 48.5 41.9 42.7 46.6 35.1 -3.3 (-5.6, -1.1) <0.01
PCV10 19.1 15.5 13.4 7.9 6.5 4.6 2.1 1.7 1.4 1.2 -34.4 (-38.4, -30.5) <0.01
PCV13-non-PCV10 10.5 10.5 6.8 5.8 5.1 5.5 5.6 3.6 5.0 4.7 -9.6 (-14.7, -4.5) <0.01
PCV13 29.5 26.0 20.2 13.7 11.6 10.2 7.7 5.2 6.3 5.9 -20.0 (-24.5, -15.6) <0.01
PCV15-non-PCV13 5.2 4.6 6.7 4.8 5.4 6.1 4.5 5.0 5.7 3.9 -1.6 (-6.0, 2.8) 0.42
PCV15 34.7 30.6 27.0 18.6 16.9 16.3 12.2 10.2 12.0 9.7 -14.6 (-17.5, -11.7) <0.01
PCV20-non-PCV15 7.9 8.8 8.4 11.0 10.8 16.0 14.2 16.7 16.1 13.0 8.1 (3.8, 12.3) <0.01
PCV20 42.6 39.4 35.4 29.6 27.7 32.3 26.4 26.9 28.1 22.7 -5.8 (-7.7, -3.9) 0.03
PPV23 44.4 42.0 38.9 32.8 31.2 36.3 31.4 32.2 34.3 25.8 -4.4 (-6.8, -2.0) <0.01
PPV23-non-PCV13 15.6 16.6 18.6 19.3 19.9 26.1 23.7 27.0 27.9 19.9 5.2 (0.7, 9.7) 0.03
PPV23-non-PCV20 2.6 3.2 3.5 3.5 3.7 4.0 5.0 5.3 6.2 3.1 5.7 (-2.2, 13.6) 0.14
Finland
Total 32.3 30.4 33.7 30.2 32.5 38.0 36.1 37.2 32.5 31.4 0.9 (-1.0, 2.7) 0.32
PCV10 18.5 15.4 14.8 10.7 8.6 6.7 4.9 3.9 3.9 1.6 -25.0 (-31.7, -18.3) <0.01
PCV13-non-PCV10 5.9 6.4 6.3 7.8 11.2 13.5 14.3 15.8 12.0 11.5 10.3 (4.9, 15.8) <0.01
PCV13 24.4 21.8 21.1 18.5 19.8 20.3 19.2 19.7 15.9 13.1 -4.9 (-7.5, -2.2) <0.01
PCV15-non-PCV13 2.5 2.8 2.7 2.7 3.9 4.5 4.9 3.7 3.2 3.8 5.1 (1.3, 8.8) 0.01
PCV15 26.8 24.6 23.8 21.1 23.7 24.7 24.1 23.4 19.1 16.9 -5.0 (-9.2, -0.9) 0.01
PCV20-non-PCV15 0.7 1.8 2.4 2.3 2.7 2.9 2.8 2.6 2.6 3.5 11.4 (0.5, 22.2) 0.04
PCV20 27.5 26.4 26.2 23.4 26.4 27.6 26.8 26.0 21.7 20.4 -2.2 (-4.2, -0.2) 0.03
PPV23 27.7 26.6 27.2 24.0 25.9 27.5 26.7 26.4 22.3 21.3 -2.1 (-3.8, -0.4) 0.02
PPV23-non-PCV13 4.8 5.9 6.7 6.5 7.8 8.3 8.4 7.6 7.1 8.3 4.7 (1.5, 7.9) 0.01
PPV23-non-PCV20 1.7 1.3 1.6 1.6 1.2 1.0 0.7 1.3 1.3 1.1 -5.0 (-9.2, -0.9) 0.02
Norway
Total 54.0 51.5 42.6 38.8 38.3 37.4 44.1 37.8 38.5 38.1 -3.3 (-5.5, -1.0) <0.01
PCV10 14.8 13.3 9.8 6.3 5.6 3.0 3.1 1.7 1.3 1.8 -28.2 (-34.3, -22.2) <0.01
PCV13-non-PCV10 12.4 11.4 8.4 4.9 4.9 4.4 5.8 6.8 6.1 5.5 -7.5 (-13.9, -1.0) 0.03
PCV13 27.2 24.7 18.2 11.2 10.5 7.4 8.9 8.6 7.4 7.3 -15.2 (-20.1, -10.2) <0.01
PCV15-non-PCV13 8.5 9.2 7.4 9.6 6.9 9.7 11.6 7.9 8.4 6.5 -1.1 (-4.9, 2.7) 0.52
PCV15 35.7 33.9 25.6 20.7 17.4 17.1 20.5 16.5 15.8 13.7 -9.8 (-15.5, -7.1) <0.01
PCV20-non-PCV15 5.2 4.9 4.8 5.1 5.4 4.9 6.9 5.7 6.7 6.5 3.5 (1.7, 5.2) <0.01
PCV20 40.9 38.8 30.4 25.8 22.8 22.0 27.3 22.2 22.5 20.2 -7.0 (-9.7, -4.4) <0.01
PPV23 40.3 39.3 31.1 26.6 24.8 23.3 29.2 26.2 25.3 25.3 -4.8 (-7.7, -1.8) <0.01
PPV23-non-PCV13 14.5 15.5 13.5 15.7 14.4 16.1 20.4 17.8 18.1 18.1 3.2 (1.7, 4.7) <0.01
PPV23-non-PCV20 0.9 1.4 1.3 1.0 2.1 1.6 1.9 4.2 3.0 5.1 17.4 (11.9, 23.0) <0.01
Sweden
Total 47.0 41.1 44.3 41.6 38.6 41.1 43.7 42.9 41.9 41.8 -0.5 (-1.9, 0.8) 0.39
PCV10 N/A 11.5 9.3 5.7 5.1 3.1 2.8 2.2 1.8 1.7 -25.4 (-29.7, -21.0) <0.01
PCV13-non-PCV10 N/A 10.3 10.3 11.4 8.7 9.8 9.6 10.3 12.0 10.7 0.8 (-1.4, 3.1) 0.41
PCV13 N/A 21.8 19.6 17.1 13.8 12.9 12.4 12.5 13.8 12.4 -6.8 (-8.7, -5.0) <0.01
PCV15-non-PCV 13 N/A 6.7 7.1 7.0 6.6 6.1 6.3 5.4 5.0 3.5 -7.2 (-12.3, -2.0) 0.01
PCV15 N/A 28.5 26.8 24.1 20.4 19.0 18.7 17.9 18.8 15.8 -6.8 (-8.7, -5.0) <0.01
PCV20-non-PCV 15 N/A 3.3 4.5 4.9 4.2 6.2 7.3 7.1 6.8 8.1 10.2 (6.9, 13.5) <0.01
PCV20 N/A 31.8 31.3 29.0 24.6 25.2 26.0 24.9 25.5 24.0 -3.3 (-4.7, -1.9) <0.01
PCV13 N/A 21.8 19.6 17.1 13.8 12.9 12.4 12.5 13.8 12.4 -6.8 (-8.7, -5.0) <0.01
PPV23 N/A 31.1 32.6 30.1 26.7 28.0 29.0 27.2 28.1 26.6 -2.0 (-3.1, -0.8) <0.01
PPV23-non-PCV13 N/A 11.8 13.7 14.1 13.2 15.5 16.9 15.2 14.5 14.5 2.3 (-0.2, 4.8) 0.07
PPV23-non-PCV20 N/A 1.9 2.0 2.2 2.5 3.1 3.3 2.8 2.7 2.9 5.8 (2.6, 9.1) <0.01